Up to 12,853,470 Shares

Common Stock

This prospectus supplement relates to the offer and resale by the selling stockholders (the "selling stockholders") identified in this prospectus supplement of up to an aggregate of 12,853,470 shares of our common stock, par value $0.01 per share (the "common stock"), which includes 2,412,632 shares issuable upon the exercise of the pre-funded warrants. The 10,440,838 shares of our common stock and pre-funded warrants to purchase up to 2,412,632 shares of our common stock were sold to the selling stockholders in a private placement that closed on July 24, 2026.

We are not selling any shares of common stock under this prospectus supplement and will not receive any proceeds from the sale by the selling stockholders of such shares.